News

Home » News

9 things to keep in mind while buying an health insurance cover

New Delhi: Health costs are only sky rocketing by the day. According to HDFC health, inflation in medicare is higher than inflation in food or other commodities. The demand for medicare in India is growing at over 25% every year. Subsequently, costs of hospitalisation and surgeries are spiralling as well. While individuals are aware of the importance of health insurance, there are just so many to choose from. A variety of plans, sub-plans and costs adds to the confusion. Therefore, it is advisable to ... Read more

National Pharmaceutical Pricing Authority (India) cuts prices of malaria, HIV, cancer drugs by up to 45%

Prices of 22 essential drugs used for treatment of cancer, HIV, bacterial infections and malaria among others, have been capped by the government, reducing the cost in the range of 10-45 per cent. Drug price regulator NPPA has also fixed the retail price of 13 formulations. "NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013," the National Pharmaceutical Pricing Authority (NPPA) said in a statement. When ... Read more

A paper-based device (US$ 1) developed to spot poor-quality medicines

Washington: Scientists have developed a simple, inexpensive paper-based device which can identify poor-quality or degraded medications within minutes. The developing world is awash in substandard, degraded or falsified medications, which can either directly harm users or deprive them of needed treatment, researchers said. With internet sales of medications on the rise, people everywhere are increasingly at risk, they said. "People who do not have access to the best-quality medicines also do not have as many resources to buy the analytical instrumentation to detect the ... Read more

One of the leading University of India has make Plagiarism report mandatory at PG level

Bhopal India: Rajiv Gandhi Proudhyogiki Vishwavidyalaya (RGPV) has made it mandatory for M Tech/M.Pharm students to submit plagiarism report before filing dissertation, thesis and PhD. The rule will be implemented from July 2016. Exam controller Mohan Sen said the rule would also be applicable for Masters of Engineering (ME) students. "Rule will be applicable for affiliated colleges and institutions of RGPV," said Sen. RGPV authorities have made it clear that in the absence of plagiarism report, the university will not accept the ... Read more

Narayana Health, Infosys Foundation invest for da Vinci robotic surgical system, sets up Institute to train surgeons, to offset shortfall of expertise

Narayana Health has established a dedicated Institute of Robotic Surgery along with Infosys Foundation to make up for the paucity of expertise in this specialty. It invested around Rs.15 crore, of which Infosys Foundation chipped in Rs.8 crore, to install da Vinci Robotic Surgery System, a US FDA approved technology manufactured by Intuitive Surgical, Inc. Bengaluru-based Vattikutti Technologies is the authorized distributors of da Vinci Robotic Surgery System in India which provides sales, service and support to the hospital and surgeons. To begin ... Read more

Sun Pharma Q1 net seen at Rs 1894 cr, US sales likely at $598

SunPharma India, is expected to post net profit at Rs 1894.4 crore in April-June quarter from Rs 479 crore in corresponding quarter last fiscal. In Q1FY16, the company had one offs charges on impairment of goodwill to the tune of Rs 685 crore. According to a CNBC-TV18 poll, the drug major is likely to see revenue growth of 20.2 percent at Rs 7876.6 crore in Q1 against Rs 6552.2 crore in year-ago period. Sales growth is likely to to be led by ... Read more

India: Six bulk drugs and medical devices ”parks” to come up

The government of Indian would be developing three bulk drugs and three medical devices parks at an investment of INR 60,000 crore (US $ 9.23 bn). It is expected that once these parks are established, they would bring down the costs of production for bulk drugs and devices by 30 per cent and would also facilitate domestic manufacturing thereby curbing imports to a great extent. Bulk drugs are used as raw materials in the pharmaceutical industry. The government would ... Read more

India: National Reference Standards for vaccines released

The Indian Pharmacopeia Commission (IPC) has released the national reference standards, specifically referred as the Indian Pharmacopoeia Reference Substances (IPRS Vaccines), the first such initiative to be undertaken of its kind. The standards would include IP monographs which act as the national reference standards for vaccines. The Indian Pharmacopeia Commission (IPC) has released the national reference standards, specifically referred as the Indian Pharmacopoeia Reference Substances (IPRS Vaccines), the first such initiative to be undertaken of its kind. The standards would include ... Read more

Indian Pharma sector to reach US $ 55 bn by 2020

The Indian pharmaceutical market would be worth US$ 55 bn by 2020, becoming the sixth largest market in the world as stated by India's ambassador to the US, Shri Arun Singh who inaugurated the 34th annual convention of American Association of Physicians of Indian Origin in New York recently. India is likely to rank amongst the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size, he added. India is the largest provider of generic drugs ... Read more

Sun Pharma’s new version of anti cancer drug in six European countries

Sun Pharma, India's largest drug company has rolled out InfuSMART the first ever ready to administer version of anti cancer drug gemcitabine in six countries of Europe including Netherlands, UK, Spain, Germany, Italy and France. The company stated that InfuSMART will play an increasing role due to its efficiency in parameters of improved safety, convenience, saving time and providing differentiating solutions . The product would be available in a bag. The company has received regulatory approval to sell gemcitabine InfuSMART in ... Read more
Next Page »